Myriad Genetics survey: Women have widespread confusion and misconceptions about ovarian cancer screening

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, today revealed new nationwide survey results indicating widespread confusion and misconceptions about ovarian cancer screening among a majority of women.

6 ways the FDA can improve medical device recalls

Lawmakers and patients have called for scrutiny of the Food and Drug Administration’s medical device recall oversight after several high-profile recalls in the last five

March 18, 2024

Preterm birth and infant mortality measures in U.S. remain stubbornly high

Preterm births and infant mortality are at alarming levels in the U.S., according to a new report published on Thursday by March of Dimes. In

November 17, 2023

Long-Term Data Support Efficacy, Safety of New Schizophrenia Drug

Recently approved xanomeline and trospium chloride (Cobenfy) demonstrated long-term efficacy and safety in patients with schizophrenia, long-term results from the phase III EMERGENT-4 trial showed.

November 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.